TARGETING THE CD6-ALCAM T CELL COSTIMULATORY PATHWAY AFTER ALLOGENEIC CELL TRANSPLANTATION FOR ACUTE GRAFT VERSUS HOST DISEASE (AGVHD) TREATMENT USING ANTI-CD6 MONOCLONAL ANTIBODY ITOLIZUMAB

被引：0
|
作者：
Rambaldi, B. [1 ,2 ,3 ]
Kim, H. T. [4 ]
Arihara, Y. [1 ,2 ,5 ]
Asano, T. [1 ,2 ,6 ]
Reynolds, C. [1 ,2 ]
Manter, M. [1 ,2 ]
Halpern, M. [1 ,2 ]
Weber, A. [1 ,2 ]
Koreth, J. [1 ,2 ]
Cutler, C. [1 ,2 ]
Gooptu, M. [1 ,2 ]
Nikiforow, S. [1 ,2 ]
Ho, V. T. [1 ,2 ]
Antin, J. H. [1 ,2 ]
Romee, R. [1 ,2 ]
Ampudia, J. [7 ]
Ng, C. [7 ]
Connelly, S. [7 ]
Soiffer, R. J. [1 ,2 ]
Ritz, J. [1 ,2 ]
机构：
[1] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA
[2] Harvard Med Sch, Boston, MA 02115 USA
[3] Univ Milao Bicocca, PhD Program Translat & Mol Med DIMET, Milan, Italy
[4] Harvard TH Chan Sch Publ Hlth, Dana Farber Canc Inst, Dept Data Sci, Boston, MA USA
[5] Sapporo Med Univ, Dept Med Oncol, Sapporo, Hokkaido, Japan
[6] Himeji Red Cross Hosp, Dept Hematol & Oncol, Himeji, Hyogo, Japan
[7] Equillium, San Diego, CA USA
来源：
HAEMATOLOGICA | 2022年 / 107卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
C70
引用
收藏
页码：55 / 55
页数：1
相关论文
共 50 条
  • [31] Low dendritic cell (DC) count after allogeneic stem cell transplantation (SCT) predicts death, relapse, and acute graft-versus-host disease (AGVHD).
    Reddy, V
    Iturraspe, J
    Schold, J
    Meier-Kriesche, HU
    Tzolas, A
    Greene, S
    Boyette, R
    Foster, J
    Wingard, J
    BLOOD, 2003, 102 (11) : 151A - 151A
  • [32] Low circulating dendritic cell count after allogeneic stem cell transplantation (SCT) predicts death, relapse, and acute graft-versus-host disease (AGVHD)
    Reddy, V
    Iturraspe, JA
    Tzolas, AC
    Meier-Kriesche, HU
    Schold, J
    Greene, S
    Wingard, JR
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2004, 10 (02) : 25 - 25
  • [33] CD25 Blockade Delays Regulatory T Cell Reconstitution and Does Not Prevent Graft-versus-Host Disease After Allogeneic Hematopoietic Cell Transplantation
    Locke, Frederick L.
    Pidala, Joseph
    Storer, Barry
    Martin, Paul J.
    Pulsipher, Michael A.
    Chauncey, Thomas R.
    Jacobsen, Niels
    Kroeger, Nicolaus
    Walker, Irwin
    Light, Susan
    Shaw, Bronwen E.
    Beato, Francisca
    Laport, Ginna G.
    Nademanee, Auayporn
    Keating, Armand
    Socie, Gerard
    Anasetti, Claudio
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2017, 23 (03) : 405 - 411
  • [34] Immunosuppressive treatment of severe acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation
    Zupan, IP
    Zver, S
    Pretnar, J
    TRANSPLANTATION PROCEEDINGS, 2002, 34 (07) : 2931 - 2933
  • [35] Regulatory T-cells in the graft and the risk of acute graft-versus-host disease after allogeneic stem cell transplantation
    Wolf, Dominik
    Wolf, Anna Maria
    Fong, Dominic
    Rumpold, Holger
    Strasak, Alexander
    Clausen, Johannes
    Nachbaur, David
    TRANSPLANTATION, 2007, 83 (08) : 1107 - 1113
  • [36] Anti-CD25 Monoclonal Antibody for Graft-Versus-Host Disease Prophylaxis Following Unrelated Donor Peripheral Blood Stem Cell Transplantation
    Fang, Jun
    Hu, Chenghao
    Hong, Mei
    Wu, Qiuling
    You, Yong
    Zhong, Zhaodong
    Zhang, Ran
    Li, Weiming
    Song, Shanjun
    Zou, Ping
    Hu, Yu
    Xia, Linghui
    BLOOD, 2011, 118 (21) : 1738 - 1738
  • [37] Humanized Anti-CD25 Monoclonal Antibody Replacing MTX for Graft-Versus-Host Disease Prophylaxis in Haploidentical Hematopoietic Stem Cell Transplantation
    Huang, Zhenli
    Zhang, Ran
    Small, Donald
    Zhu, Ruiqi
    Shi, Wei
    Xia, Linghui
    BLOOD, 2023, 142
  • [38] Selective CD4(+) T cell depletion does not prevent graft versus host disease after allogeneic bone marrow transplantation (BMT).
    Nagler, A
    Or, R
    Naparstek, E
    Aker, A
    Condiotti, R
    Nabet, C
    Samuel, S
    Slavin, S
    EXPERIMENTAL HEMATOLOGY, 1996, 24 (09) : 600 - 600
  • [39] Clinical Outcomes Related to the Use of Monoclonal Antibody Therapy for Steroid Refractory Acute Graft-Versus Host Disease after Allogeneic Hematopoietic Cell Transplantation
    Yalniz, Fevzi
    Hefazi, Mehrdad
    McCullough, Kristen B.
    Litzow, Mark
    Hogan, William J.
    Wolf, Robert C.
    Alkhateeb, Hassan B.
    Kansagra, Ankit
    Damlaj, Moussab
    Patnaik, Mrinal M.
    BLOOD, 2016, 128 (22)
  • [40] MURINE MONOCLONAL ANTI-T CELL ANTIBODIES FOR TREATMENT OF REFRACTORY ACUTE GRAFT-VERSUS-HOST DISEASE
    MARTIN, PJ
    REMLINGER, K
    HANSEN, JA
    STORB, R
    THOMAS, ED
    TRANSPLANTATION PROCEEDINGS, 1984, 16 (06) : 1494 - 1495
12345